Latest Entitlement Offers News

Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.

Mayfield Childcare’s HY26 results reveal a 6% revenue decline and deepening statutory loss, offset by operational improvements and strategic restructuring.

The Calmer Co. International Limited posted a record $8.1 million revenue for FY26, driven by retail and wholesale growth, yet recorded a $3.8 million net loss amid ongoing funding challenges and strategic investments.

archTIS Limited’s FY2026 results reveal a 120% surge in sales revenue to $13.35 million, fueled by the Spirion acquisition, yet losses ballooned to $16.3 million reflecting higher operating costs and integration expenses.

L1 Gold Fund Limited (ASX:LGF) has launched a retail entitlement offer aiming to raise up to $261.7 million by issuing one new share for every three held, priced at $2.25 each. This follows a $254.9 million institutional placement and entitlement offer completed earlier in August.

X2M Connect Limited lifted revenue by 38% to $8.94 million in FY26, halving its net loss while laying groundwork for a new data centre business.

Genetic Technologies Limited slashed its net loss by nearly 88% in FY2025 following a Deed of Company Arrangement and exit from voluntary administration, pivoting to a corporate office model after selling its operating businesses.

Babylon Pump & Power has successfully raised $7.27 million through an entitlement offer combining cash and debt conversion, strengthening its focus on water management rentals. Blue Hire founder Byron Ynema joins the board as the largest shareholder.

WAM Active Limited delivered a historic 75.5% investment portfolio return in FY2026, driving net profit after tax up 355% to $33.8 million and declaring fully franked dividends totaling 9.4 cents per share.

Australian Dairy Nutritionals reported a 47% reduction in net loss for FY26, driven by a 66% revenue jump in its nutritional powders segment, which now makes up 70% of total revenue.

MA Credit Income Trust (ASX:MA1) posted a robust 8.56% net return for FY2026, surpassing its target, alongside a fully subscribed $190.5 million capital raise and strategic buy-back initiatives.

Biotron Limited posted a $1.52 million net loss for FY2026, driven by integration and R&D costs following its Sedarex acquisition, while progressing regulatory and clinical development for its SedRxTM anaesthetic and antiviral pipeline.